Close

Kakao Healthcare Enters into Agreement with Novo Nordisk Pharma

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

Thermo Fisher Receives FDA Approval for...

The world leader when it comes to serving science,...

Virtual MRI Imaging with AI Aids...

During the magnetic resonance imaging (MRI) procedures, contrast agents...

Kakao Healthcare announced that it has signed a business agreement with Novo Nordisk Pharma, aimed at revolutionising the provision of smart healthcare services for chronic illnesses.

This collaboration entails the integration of Kakao Healthcare’s innovative digital blood sugar management service, known as ‘Project Gamma,’ with Novo Nordisk’s forthcoming ‘Malia Smart Sensor,’ slated for release later this year. This sensor is poised to usher in a new era of patient convenience, capable of detecting real-time fluctuations in blood sugar levels, facilitating insulin injections, and seamlessly recording historical data.

By combining their strengths, these two leaders are set to reshape chronic disease management, ushering in a new era of personalised and efficient healthcare services. The integration of Novo Nordisk’s expertise and Kakao Healthcare’s technological advancements promises to empower patients both at home and abroad in effectively managing their health.

The strategic partnership between Kakao Healthcare and Novo Nordisk Pharmaceuticals holds the promise of practical solutions that will positively impact the lives of six million Koreans grappling with diabetes.

Latest stories

Related stories

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Virtual MRI Imaging with AI Aids Better Tumor Detection

During the magnetic resonance imaging (MRI) procedures, contrast agents...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back